Key facts
- MPM BioImpact LLC filed SCHEDULE 13G for Climb Bio, Inc. Common Stock, par value $0.0001 per share (CLYM).
- Disclosed ownership: 5.6%.
- Date of event: 31 Dec 2025.
MPM BioImpact LLC - 31 Dec 2025 SCHEDULE 13G Report for Climb Bio, Inc. Common Stock, par value $0.0001 per share (CLYM)
- Filing Manager
- MPM BioImpact LLC
- Reporting Manager
- MPM BioImpact LLC
- Symbol
- CLYM
- Shares outstanding
- 47,705,000 shares
- Disclosed Ownership
- 2,671,480 shares
- Ownership
- 5.6%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 16:09:59 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Key filing fact
MPM BioImpact LLC disclosed 5.6% ownership in Climb Bio, Inc. Common Stock, par value $0.0001 per share (CLYM) on 31 Dec 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 16:09.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC | 5.6% | 2,671,480 | 2,671,480 | 0 | Christopher Wolf | Chief Financial Officer |
CIK / CUSIP context first